Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
about
Epidemiology and clinical course of Crohn's disease: results from observational studiesInflammatory bowel disease surgery in the biologic eraCurrent status of biosimilars in the treatment of inflammatory bowel diseasesHow should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Current management of anal fistulas in Crohn's diseaseMedical Therapy of Fibrostenotic Crohn's DiseaseOptimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalHepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel diseaseOptimising monitoring in the management of Crohn's disease: a physician's perspectiveUse of the tumor necrosis factor-blockers for Crohn's diseaseComparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular ViewTHERAPIES FOR CROHN'S DISEASE: a clinical updateUstekinumab for the treatment of Crohn's disease.Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.Biological treatment of Crohn's disease.Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study.Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study.Discontinuation of Scheduled Infliximab in Crohn's Patients With Clinical Remission: A Retrospective Single-Center Study.Diagnosis and management of intestinal Behçet's disease.Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart reviewManagement of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Medical management of Crohn's disease.Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Current status of thiopurine analogues in the treatment in Crohn's disease.Mucosal healing did not predict sustained clinical remission in patients with IBD after discontinuation of one-year infliximab therapy.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.Infliximab therapy for moderately severe Crohn's disease and ulcerative colitis: a retrospective comparison over 6 years.Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.Current treatment of ulcerative colitisRisk of postoperative recurrence and postoperative management of Crohn's diseaseInfliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosaInfliximab to treat Crohn's disease: an update.Inhibition of 4-1BBL-regulated TLR response in macrophages ameliorates endotoxin-induced sepsis in mice.Combination therapy for the treatment of Crohn's disease.Specialized enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis.Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's diseaseCrucial steps in the natural history of inflammatory bowel disease.Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease
P2860
Q22241217-C4B49D38-F261-435A-9B73-5007B1474D72Q26745627-B650CCFB-4BF9-40CE-9168-CC6241EE326AQ26765350-0509D63D-7305-4339-B733-7990ADD4EC65Q26777409-08C50248-7824-4886-9AE9-E1CDAD7A23EDQ26777667-96848A99-C41B-460C-B19E-77BAF1466C44Q26777724-ABFBF6AD-DF3A-44BD-AD1A-3416C93376F0Q26801119-0DBCF3E5-023B-4A29-B41A-0E4AF48279D2Q26827444-370E2209-CA45-4A69-BCC7-56B05370A460Q27007083-B8460016-4B7B-410F-A78A-6F4A130C5DB3Q27030762-FF3DB6F8-3FC4-4320-AA0B-6FB004A4D8B0Q27679553-47B6F733-DD34-4F1D-A980-3815DEB0E345Q28070271-F6B58680-7AC2-4BB1-B931-644ACCF9258BQ30390909-BC6B862F-8E41-46A0-8526-0C1F4F3F2152Q31113830-DBB711DE-12D4-43CA-A1B2-65C8BA19A07EQ33354991-2EDF3FE2-142C-4E87-8F5D-78B39D16FBECQ33501390-5185969A-6690-489C-A053-A0432AE93290Q33606172-E658BDED-7492-4FF5-A6B9-F7863B7D85CEQ33625252-96FC9059-A728-4838-98A5-4A7FDCEF37B2Q33681591-89DB9FEE-2579-4660-A0AD-FF4E8B703811Q33724975-0FF2BD61-C192-4AAF-8252-4AD6645A3496Q33819478-44E93124-CB89-40FA-8D60-FDEB83F46E67Q34046139-C6503A2D-D9AE-4925-AAD4-9FDF2B85FDC2Q34127277-AB58B229-C035-43A1-B932-B3F874BA3B70Q34147687-0FDB59EE-27CC-48E9-B7BD-96E3ABE29E43Q34235370-F8AD274B-39FF-4BE4-A87D-6E526D2EFC55Q34374449-76B53DB0-97D2-4C41-8942-4F9C04D86045Q34504710-7CB313AE-EDBE-461B-B827-334434520720Q34837921-65E43768-EA9F-4896-A51D-E21DF60B4C70Q35026410-D263D2E0-FAF6-4026-9451-981A84C92240Q35134059-DE0D8F42-51D2-4853-A02C-52F257D4E1E7Q35171533-B984396D-207A-4B4A-95ED-9D0B1DC223CAQ35171537-32625512-8E75-4FC3-9DAA-032EA8860301Q35250578-7E80818B-D3D8-4AA8-B830-5C41E8045527Q35304737-E01B112E-8A72-4D94-BFD5-151A5186B134Q35565652-D5786818-B1D9-4F6E-B890-6B9E4ACC600FQ35714202-A51ECA85-2C73-4546-9E9E-E63712240D22Q35780904-800BA3AB-57D3-44E6-965A-9EF7281CC366Q36048409-768BB06B-5DE5-4E2D-AF42-92676068759DQ36144457-ADFF0FC5-1594-4847-A1C6-F6412D7B8A02Q36330198-C60E5F02-4B21-4770-AC3D-9CF19A477EA4
P2860
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Long-term outcome of treatment ...... s from a single-centre cohort.
@en
Long-term outcome of treatment ...... s from a single-centre cohort.
@nl
type
label
Long-term outcome of treatment ...... s from a single-centre cohort.
@en
Long-term outcome of treatment ...... s from a single-centre cohort.
@nl
prefLabel
Long-term outcome of treatment ...... s from a single-centre cohort.
@en
Long-term outcome of treatment ...... s from a single-centre cohort.
@nl
P2093
P50
P356
P1433
P1476
Long-term outcome of treatment ...... ts from a single-centre cohort
@en
P2093
F Schnitzler
G Van Assche
M Ferrante
P Rutgeerts
P304
P356
10.1136/GUT.2008.155812
P407
P577
2008-10-02T00:00:00Z